Spectroflourometric and spectrophotometric methods for the determination of sitagliptin in binary mixture with metformin and ternary mixture with metformin and sitagliptin alkaline degradation product

International Journal of Biomedical Science

Volumn 7, Issue 1, 2011, Pages 62-69

  El Bagary, Ramzia I ^a   Elkady, Ehab F ^a   Ayoub, Bassam M ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Flourometry; Metformin; Pharmaceutical preparation; Sitagliptin phosphate; Spectrophotometry; Stability indicating assay

Indexed keywords

METFORMIN PLUS SITAGLIPTIN; SITAGLIPTIN;

ACCURACY; ALKALINIZATION; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DEGRADATION; DRUG DETERMINATION; DRUG HYDROLYSIS; DRUG MIXTURE; DRUG QUALITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; POWDER; PROCESS DEVELOPMENT; QUALITY CONTROL; SPECTROFLUOROMETRY; SPECTROPHOTOMETRY; TABLET FORMULATION; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 79953014520     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sekaran B, Rani P. Development and validation of spectrophotometric method for the determination of DPP4 inhibitor, Sitagliptin in its pharmaceutical dosage forms. Int. J. Pharm. Sci. 2010; 2 (4): 138.
2. Nirogi R, Kandikere V, Mudigonda K, et al. Sensitive liquid chromatography tandem mass spectrometry method for the quantification of sitagliptin, a DPP-4 inhibitor, in human plasma using liquid liquid extraction. Biomed. Chromatogr. 2008; 22: 214.
3. Dhillon S. Sitagliptin. A review of its use in the management of type 2 diabetes mellitus. Drugs. 2010; 70 (4): 489.
4. Green J, Feinglos M. New combination treatments in the management of diabetes: focus on sitagliptin-metformin. Vasc. Health Risk Manag. 2008; 4 (4): 743.
5. Zeng W, Musson D, Fisher A, et al. Determination of sitagliptin in human urine and hemodialysate using turbulent flow online extraction and tendem mass spectrophotometry. J. Pharmaceut Biomed. Anal. 2008; 46: 534.
6. Zeng W, Xu Y, Constanzer M, Woolf EJ. Determination of sitagliptinin human plasma using protein precipitation and tandem mass spectrometry. J. Chromatogr B Analyt Technol Biomed. Life Sci. 2010; 878 (21): 1817.
7. Sengupta P, Bhaumik U, Ghosh A, et al. Chatterjee B., Bose A., Pal TK, LC-MS-MS development and validation for simultaneous quantitation of metformin, glimepiride and pioglitazone in human plasma and its application to a bioequivalence study. Chromatographia. 2009; 69 (11-12): 1243.
8. Xiong Y, Zhou HJ, Zhang ZJ. A chemiluminescence sensor for determination of metformin in urine samples based on molecularly imprinted polymer. Fenxi Shiyanshi. 2006; 25 (3): 5.
9. Ali AR, Duraidi II, Saket MM, et al. Column high-performance liquid chromatographic method for the simultaneous determination of rosiglitazone and metformin in a pharmaceutical preparation. J. AOAC Int. 2009; 92 (1): 119.
10. Porta V, Schramm SG, Kano EK, et al. HPLC-UV determination of metformin in human plasma for application in pharmacokinetics and bioequivalence studies. J. Pharm. Biomed. Anal. 2008; 46 (1): 143.
11. Zhong LH, Ling X, Sun H. HPLC/MS2 detection of biguanides and sulfonylurea antidiabetics illegally mixed into traditional Chinese preparations. Yaowu Fenxi Zazhi. 2008; 28 (10): 1683.
12. EL-Ashry S, EL-Sherbeny M, EL-Sherbeny D, et al. Fluorimetric determination of some thioxanthene derivatives in dosage forms and biological fluids. J. Pharm. Biomed. Anal. 2000; 22 (5): 729.
13. Rizk M, Belal F, Ibrahim F, et al. Spectrofluorimetric analysis of certain 4-quinolone in pharmaceuticals and biological fluids. Pharmaceutica Acta Helvetiae. 2000; 74 (4): 371.
14. Belal F, Ibrahim F, Hassan SM, et al. Spectroflourimetric determination of some pharmaceutically important thioxanthene derivatives. Analytica Chimica Acta. 1991; 255 (1): 103.
15. Bebawy L, Abbas S, Fattah L, Refaat H. Application of first derivative, ratio derivative spectrophotometry, TLC-densitometry and spectrofluorimetry for the simultaneous determination of telmisartan and hydrochlorothiazide in pharmaceutical dosage forms and plasma. Il Farmaco. 2005; 60 (10): 859.
16. Toral MI, Pope S, Quintanilla S, et al. Simultaneous determination of amiloride and furosemide in pharmaceutical formulations by first digital derivative spectrophotometry. Interl. J. Pharm. 2002; 249 (2): 117.
17. Abbaspour A, Mirzajani R. Simultaneous determination of phenytoin, barbital and caffeine in pharmaceuticals by absorption (zero-order) UV spectra and first-order derivative spectra multivariate calibration methods. J. Pharm. Biomed. Anal. 2005; 38 (3): 420.
18. Satana E, Altinay S, Goger N, et al. Simultaneous determination of valsartan and hydrochlorothiazide in tablets by first derivative ultraviolet spectrophotometry and LC. J. Pharm. Biomed. Anal. 2001; 25 (6): 1009.
19. Gadila S, Batchu S, Lade S. Development and Validation of liquid chromatographic and UV derivative spectrophotometric methods for the determination of famciclovir in pharmaceutical dosage forms. Chem. Pharm. Bull. 2006; 54 (6): 819.
20. Bebawy LI. Application of TLC-densitometry, first derivative UVspectrophotometry and ratio derivative spectrophotometry for the determination of dorzolamide hydrochloride and timolol maleate. J. Pharm. Biomed. Anal. 2002; 27 (5): 737.
21. Altinoz S, Toptan S. Simultaneous determination of Indigotin and Ponceau- 4R in food samples by using Vierordt's method, ratio spectra first order derivative and derivative UV spectrophotometry. J. Fd. Comp. Anal. 2003; (16) 4: 517.
22. Hansen K, Balsells J, Dreher S, et al. First Generation Process for the Preparation of the DPP-IV Inhibitor Sitagliptin. Org. Process Res. Dev. ACS. 2005; 9 (5): 634.
23. Gallwitz B. Review of sitagliptin phosphate: a novel treatment for type 2 diabetes. Vasc health risk manag. 2007; 3 (2): 203.
24. The Indian Pharmacopoeia. 4th ed. New Delhi: The Controller of Publications. 1996; 1: 469.